SoftBank Group Corp. vs Novartis AG
Market cap comparison over time
SoftBank Group Corp.
$251.1B
Rank #58
Novartis AG
$259.7B
Rank #55
Market Cap Over Time
Year-by-Year Comparison
| Year | SoftBank Group Corp. | Novartis AG | Leader |
|---|---|---|---|
| 2026 | $251.1B | $259.7B | Novartis AG |
| 2025 | $167.8B | $227.3B | Novartis AG |
| 2024 | $87.2B | $177.6B | Novartis AG |
| 2023 | $59.5B | $163.8B | Novartis AG |
| 2022 | $52.9B | $146.3B | Novartis AG |
| 2021 | $50.5B | $134.5B | Novartis AG |
| 2020 | $74.5B | $134.7B | Novartis AG |
| 2019 | $43.6B | $142.4B | Novartis AG |
| 2018 | $33.2B | $110.8B | Novartis AG |
| 2017 | $40.4B | $104.0B | Novartis AG |
| 2016 | $35.0B | $89.6B | Novartis AG |
| 2015 | $27.4B | $100.4B | Novartis AG |
| 2014 | $32.0B | $103.4B | Novartis AG |
| 2013 | $40.7B | $76.6B | Novartis AG |
| 2012 | $13.8B | $59.2B | Novartis AG |
| 2011 | $9.7B | $52.5B | Novartis AG |
| 2010 | $12.0B | $51.1B | Novartis AG |
| 2009 | $9.3B | $50.7B | Novartis AG |
| 2008 | $6.8B | $44.5B | Novartis AG |
| 2007 | $9.8B | $50.6B | Novartis AG |
| 2006 | $9.8B | $55.9B | Novartis AG |
| 2005 | $21.2B | $53.9B | Novartis AG |
| 2004 | $7.1B | $43.8B | Novartis AG |
| 2003 | $4.6B | $42.0B | Novartis AG |
| 2002 | $1.9B | $36.9B | Novartis AG |
| 2001 | $3.0B | $43.1B | Novartis AG |
| 2000 | $5.6B | $50.7B | Novartis AG |